News

Public · Published

TAT Technologies Reports Record Third Quarter 2026 Results

TAT Technologies reported record third-quarter 2026 revenue of $55.6 million and adjusted EBITDA of $10.9 million. Revenue rose 20.2%, adjusted EBITDA rose 60.9%, and diluted earnings per share increased 57.8%. Its CEO attributed results to strong customer demand, improved product mix, and greater operational efficiency.

Published:

Updated:

What happened

TAT Technologies reported record third-quarter 2026 revenue of $55.6 million and adjusted EBITDA of $10.9 million. Revenue rose 20.2%, adjusted EBITDA rose 60.9%, and diluted earnings per share increased 57.8%. Its CEO attributed results to strong customer demand, improved product mix, and greater operational efficiency.

Confirmed

Global impact / market context

Higher revenue and adjusted EBITDA indicate that TAT converted stronger demand and its product mix into more operating earnings. If those conditions continue, the company could have more cash available to fund operations or investment, though the report excerpt does not establish that growth will persist.

Analyst inference

TAT supplies products and services to commercial and military aerospace and ground defense industries, so its results offer a company-specific signal about demand in those markets. The CEO also cited an extended Honeywell relationship, but gave no quantified revenue contribution or contract value.

Analyst inference

What to watch

  1. Check the full nine-month results and later reports for whether revenue and adjusted EBITDA gains continue; this excerpt gives no nine-month totals or forward numerical guidance. Analyst inference
  2. Watch whether management links future results to customer demand, product mix, or operational efficiency, the factors it said supported the record quarter. Analyst inference
  3. The CEO said TAT entered the final quarter with a strong backlog, meaning orders awaiting delivery, and long-term agreements; later disclosures could show how these support sales. Confirmed

Evidence

  • Original source link unavailable